New bd research tool helps scientists study cells that are often key culprits in the development of cancer and infectious diseases

Bd rhapsody™ atac-seq assay helps researchers understand dna regulation and enable advancements in precision medicine franklin lakes, n.j. , june 26, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, announced the commercial launch of a new single-cell research tool to help scientists better understand how the molecular machinery within a cell functions and how it regulates changes in a cell that can lead to cancer and other diseases.
BDX Ratings Summary
BDX Quant Ranking